MENU
CELC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Celcuity (CELC) Earnings Date & Reports
Celcuity Inc is a clinical-stage biotechnology company developing targeted therapies for multiple solid tumors... Show more
Industry: #Miscellaneous Commercial Services
A.I. Advisor
published Earnings
CELC is expected to report earnings to fall 2.08% to -140 cents per share on November 18
Q3'26
Est.
$-1.41
Q2'26
Missed
by $0.28
Q1'26
Beat
by $0.07
Q4'25
Beat
by $0.32
Q3'25
Beat
by $0.10
The last earnings report on August 13 showed earnings per share of -144 cents, missing the estimate of -115 cents. With 441.20K shares outstanding, the current market capitalization sits at 4.72B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
a biotechnology company develops novel diagnostic tests
Industry Biotechnology
Profile
Details
Industry
Miscellaneous Commercial Services
Address
16305 36th Avenue North
Phone
+1 763 392-0767
Employees
155
Web
https://www.celcuity.com